Activity of β-lapachone derivatives against rifampicin-susceptible and -resistant strains of Mycobacterium tuberculosis

Tuberculosis

Volumn 90, Issue 5, 2010, Pages 293-297

  Coelho, Tatiane S ^a   Silva, Raphael S F ^b   Pinto, Antonio V ^b   Pinto, Maria C F R ^b   Scaini, Carlos J ^a   Moura, Kelly C G ^b   Almeida Da Silva, Pedro ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Lapachone; Activity antimicrobial; Naphthoimidazoles; Phenazines

Indexed keywords

1,2 PHENYLENEDIAMINE; ACETIC ACID; ALDEHYDE; AMMONIUM ACETATE; BETA LAPACHONE; BETA LAPACHONE DERIVATIVE; CLOFAZIMINE; NAPHTHOIMIDAZOLE DERIVATIVE; NAPHTHOQUINONE; PHENAZINE DERIVATIVE; RIFAMPICIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; ASSAY; BACTERIAL STRAIN; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

ANTITUBERCULAR AGENTS; CELL LINE; DRUG RESISTANCE, MICROBIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; NAPHTHOQUINONES; PHENAZINES; RIFAMPIN;

EID: 77957191741     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tube.2010.06.001     Document Type: Article

References (33)

1. Global tuberculosis control World health organization Report http://www.who.int/tb/publications/global-report/en/ 2009 [accessed 21.05.10.]
2. S.T. Cole, and P.M. Alzari Towards new tuberculosis drugs Biochem Soc Trans 35 2007 1321 1324
3. D.B. Young, M.D. Perkins, K. Duncan, and C.E. Barry Confronting the scientific obstacles to global control of tuberculosis J Clin Invest 118 2008 1255 1265
4. Y. Zhang Themagic bullets and tuberculosis drug targets Annu Rev Pharmacol Toxicol 45 2005 529 564
5. E.M. Zager, and R. Mcnerney Multi-drug resistant tuberculosis BMC Infect Dis 8 2008 10
6. P.E.A. Silva, and J.A. Aínsa Drugs and drug interactions J.C. Palomino, S.C. Leão, V. Ritacco, Tuberculosis 2007, from basic science to patient care 2007 www.tuberculosistextbook.com available from[accessed 21.05.10.]
7. T. Adékambi, M. Drancourt, and D. Raoult The rpoB gene as a tool for clinical microbiologists Trends Microbiol 17 2008 37 45
8. J.S. Blanchard Molecular mechanisms of drug resistance in Mycobacterium tuberculosis Annu Rev Biochem 65 1996 215 239
9. W.S. Carvalho, S.S. Miranda, J.L. Pesquero, and M.A. Gomes Diagnóstico de resistência do Mycobacterium tuberculosis rifampicina utilizando-se da reaão em cadeia da polimerase Braz J Pharm Sci 43 2007 31 38
10. Y. Zhang, and L.M. Amzel Tuberculosis drug targets Curr Drug Targets 3 2002 131 154
11. A. Hudson, T. Imamura, W. Gutteridge, T. Kanyok, and P. Nunn The current anti-TB drug research and development pipeline World Health Organ behalf Spec Programme for Res Train Trop Dis 2003 1 44
12. M. Biava, G.C. Porretta, G. Poce, S. Supino, D. Deidda, and R. Pompei Antimycobacterial agents. Novel diarylpyrrole derivatives of BM212 endowed with high activity toward Mycobacterium tuberculosis and low cytotoxicity J Med Chem 49 2006 4946 4952
13. J.C. Palomino, D.F. Ramos, and P.E.A. Silva New anti-tuberculosis drugs: strategies, sources and new molecules Curr Med Chem 16 2009 1898 1904
14. G.G.F. Nascimento, J. Locatelli, P.C. Freitas, and G.L. Silva Antibacterial activity of plant extracts and phytochemicals on antibiotic resistant bacteria Braz J Microbiol 31 2000 247 256
15. M.B. Falkenberg Quinonas C.M.O. Simões, E.P. Schenkel, G. Gosmann, J.C.P. Mello, L.A. Mentz, P.R. Petrovick, Farmacognosia: da planta ao medicamento 2004
16. M.N. Da Silva, V.F. Ferreira, and M.C.B.V. De Souza Um panorama atual da química e da farmacologia de naftoquinonas, com ênfase na β-Lapachona e derivados Quim. Nova. 26 2003 407 416
17. R.H. Thomson Naphtaquinones. Naturally occurring quinones 1971 Academic Press
18. A. Kamal, A.H. Babu, A.V. Ramana, R. Sinha, J.S. Yadav, and S.K. Arora Antitubercular agents. Part 1: synthesis of phthalimido- and naphthalimido-linked phenazines as new prototype antitubercular agents Bioorg Med Chem Lett 15 2005 1923 1926
19. V.F. Andrade-Neto, M.O.F. Goulart, J.D.S. Filho, M.J. Da Silva, M.C.F.R. Pinto, and A.V. Pinto Antimalarial activity of phenazines from lapachol, beta-lapachone and its derivatives against Plasmodium falciparum in vitro and Plasmodium berghei in vivo Bioorg Med Chem Lett 14 2004 1145 1949
20. M. Ettlinger Hydroxynaphthoquinones II cyclization and the basicity and interconversion of ortho and para quinones J Am Chem Soc 72 1950 3090 3095
21. Pinto CN. Quinonas bioativas de Tabebuia: Reatividade e potencial na síntese de heterocíclicos. Doutoral Thesis, UFRJ. Rio de Janeiro; 1998.
22. K.C.G. De Moura, F.S. Emery, C.N. Pinto, M.C.F.R. Pinto, A.P. Dantas, and K. Salomão Trypanocidal activity of isolated naphthoquinones from Tabebuia and some heterocyclic derivatives: a review from an interdisciplinary study J Braz Chem Soc 12 2001 325 338
23. K.C.G. De Moura, A.V. Pinto, F.S. Emery, M.C.F.R. Pinto, S.L. Castro, and K. Salomão Studies on the trypanocidal activity of semi-synthetic pyran[b-4,3]naphtho[1,2-d]imidazoles from β-lapachone Eur J Med Chem 39 2004 639 645
24. Silva RSF. Síntese de fenazinas e derivados lactônicos e halogenados a partir de naftoquinonas naturais com atividade contra Mycobacterium tuberculosis. Doutoral Thesis - NPPN/UFRJ. Rio de Janeiro; 2009.
25. J.C. Palomino, A. Martin, M. Camacho, H. Guerra, J. Swings, and F. Portaels Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis Antimicrob Agents Chemother 46 2002 2720 2722
26. M. Dubin, S.H. Fernandez-Villamil, and A.O.M. Stoppani Cytotoxicity of β-lapachone, an o-naphthoquinone with possible therapeutic use Medicina 61 2001 343 350
27. R.F.S. Menna-Barreto, J.R. Corrêa, A.V. Pinto, M.J. Soares, and S.L. Castro Mitochondrial disruption and DNA fragmentation in Trypanosoma cruzi induced by naphthoimidazoles synthesized from β-lapachone Parasitol Res 101 2007 895 905
28. S.B. Ferreira, F.C. Silva, F.A.F.M. Bezerra, M.C.S. Loureno, C.R. Kaiser, and A.C. Pinto Synthesis of - and -Pyran naphthoquinones as a new class of antitubercular agents Arch Pharm (Weinheim) 343 2010 81 90
29. J.B. Laursen, and J. Nielsen Phenazine natural products: biosynthesis, synthetic analogues, and biological activity Chem Rev 104 2004 1663 1686
30. K.C. Murdock, Y.I. Lin, J.P. Thomas, and S.A. Lang Antitubercular 2,8-bis (alkylaminomethyl) phenazines J Med Chem 21 1978 403 405
31. T. Bhaduri, T.K. Bagui, D. Sikder, and V. Nagaraja DNA topoisomerase I from Mycobacterium smegmatis J Biol Chem 273 1998 13925 13932
32. Y.C. Tse-Dinh Bacterial topoisomerase I as a target for discovery of antibacterial compounds Nucleic Acids Res 37 2009 731 737
33. B. Cheng, F. Liu, and Y.C. Tse-Dinh Compounds with antibacterial activity that enhance DNA cleavage by bacterial DNA topoisomerase I J Antimicrob Chemother 59 2007 640 645